Skip to main content
Erschienen in: Acta Diabetologica 2/2013

01.04.2013 | Original Article

The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea

verfasst von: Mi-Oh Roh, Chan-Hee Jung, Bo-Yeon Kim, Ji-Oh Mok, Chul-Hee Kim

Erschienen in: Acta Diabetologica | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Few studies were performed to evaluate the prevalence of latent autoimmune diabetes in adults (LADA) and the difference of chronic complications between LADA, T1DM, and T2DM in Korean. The aim of this study is to establish the prevalence of LADA in a diabetic clinic of Soonchunhyang University hospital and to compare the phenotypic characteristics according to DM classification based on positivity of glutamic acid decarboxylase antibodies (GADA). Also, another important point concerns the occurrence of diabetes chronic microvascular complications in LADA. 323 patients who were checked GADA among diabetic patients admitted at Soonchunhyang University hospital were recruited. Twenty-eight patients (8.7%) were identified as positive for GADA. 11.5% (n = 37) were diagnosed with T1DM and 5.3% (n = 17) were diagnosed with LADA. GADA titer showed significant negative correlation with age of onset, total cholesterol (TC), triglyceride (TG), fasting C-peptide, stimulated C-peptide, BMI, and positive correlation with HbA1C and HDL-C. Compared with those that tested negative for GADA, patients with GADA positive had lower values of onset age, BMI, TC, TG, LDL-C, fasting, and stimulated C-peptide levels and higher values of HbA1C. A significant gradual increase of values was observed for the onset age, BMI, SBP, DBP, fasting, and stimulated C-peptide across the T1DM, LADA, and T2DM subgroups. Concerning the chronic complications there was no difference in prevalence of retinopathy, neuropathy and nephropathy between three groups. Of LADA patients, 12 patients were receiving insulin treatment and mean time to insulin initiation was about 37 months. In conclusion, because our study suggests LADA subgroups in Korea appear to have a faster decline in C-peptide levels, it is worth detecting the patients with LADA early and effort to preserve beta cell function. Furthermore, our results showed that the prevalence of microvascular complication was comparable between the subgroups.
Literatur
1.
Zurück zum Zitat Groop LC, Bottazo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35:237–241PubMedCrossRef Groop LC, Bottazo GF, Doniach D (1986) Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 35:237–241PubMedCrossRef
2.
Zurück zum Zitat Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment. Diabetes 54:S68–S72PubMedCrossRef Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, β-cell function, and treatment. Diabetes 54:S68–S72PubMedCrossRef
3.
Zurück zum Zitat Turner R, Statton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef Turner R, Statton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288–1293PubMedCrossRef
4.
Zurück zum Zitat Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1025–1064 Zimmet PZ (1995) The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1025–1064
5.
Zurück zum Zitat Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMedCrossRef Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150–157PubMedCrossRef
6.
Zurück zum Zitat Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G (2004) A clinically oriented approach increases the efficacy of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21:456–459PubMedCrossRef Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G (2004) A clinically oriented approach increases the efficacy of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21:456–459PubMedCrossRef
7.
Zurück zum Zitat Ruige JB, Batstra MR, Aanstoot HJ, Bouter LM, Bruining GJ, de Neeling JND, Heine RJ (1997) Low prevalence of antibodies to GAD 65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef Ruige JB, Batstra MR, Aanstoot HJ, Bouter LM, Bruining GJ, de Neeling JND, Heine RJ (1997) Low prevalence of antibodies to GAD 65 in a 50- to 74-year-old general Dutch population. The Hoorn Study. Diabetes Care 20:1108–1110PubMedCrossRef
8.
Zurück zum Zitat Bosi EP, Garancini MP, Poggiali F, Bonifacio E, Gallus G (1999) Low prevalence of islet autoimmunity in adult diabetes and low predictive value of autoantibodies in the general adult population of northern Italy. Diabetologia 42:840–844PubMedCrossRef Bosi EP, Garancini MP, Poggiali F, Bonifacio E, Gallus G (1999) Low prevalence of islet autoimmunity in adult diabetes and low predictive value of autoantibodies in the general adult population of northern Italy. Diabetologia 42:840–844PubMedCrossRef
9.
Zurück zum Zitat Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368:1681–1688PubMedCrossRef Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368:1681–1688PubMedCrossRef
10.
Zurück zum Zitat Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey. Diabetes Care 29:226–231PubMedCrossRef Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon DK, Baik SH, Choi DS, Choi KM (2006) Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey. Diabetes Care 29:226–231PubMedCrossRef
11.
Zurück zum Zitat Torn C (2003) C-peptide and autoimmune markers in diabetes. Clin Lab 49:1–10PubMed Torn C (2003) C-peptide and autoimmune markers in diabetes. Clin Lab 49:1–10PubMed
12.
Zurück zum Zitat Borg H, Gottsater A, Fernlund P, Sundkvist G (2002) A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754–1762PubMedCrossRef Borg H, Gottsater A, Fernlund P, Sundkvist G (2002) A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754–1762PubMedCrossRef
13.
Zurück zum Zitat Arikan E, Sabuncu T, Ozer EM, Hatemi H (2005) The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications 19:254–258PubMedCrossRef Arikan E, Sabuncu T, Ozer EM, Hatemi H (2005) The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications 19:254–258PubMedCrossRef
14.
Zurück zum Zitat Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Feed MI (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with Type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMedCrossRef Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Feed MI (2004) Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with Type 2 diabetes in North America and Europe. Diabetes 53:3193–3200PubMedCrossRef
15.
Zurück zum Zitat Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010PubMedCrossRef Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J (2001) Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005–1010PubMedCrossRef
16.
Zurück zum Zitat Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667–674PubMedCrossRef Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667–674PubMedCrossRef
17.
Zurück zum Zitat Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TME (2008) Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med 25:1245–1250PubMedCrossRef Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TME (2008) Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med 25:1245–1250PubMedCrossRef
18.
Zurück zum Zitat Balme M, McAllister I, Davis WA, Davis TM (2002) Retinopathy in latent autoimmune diabetes of adults: the Fremantle Diabetes Study. Diabet Med 19:602–605PubMedCrossRef Balme M, McAllister I, Davis WA, Davis TM (2002) Retinopathy in latent autoimmune diabetes of adults: the Fremantle Diabetes Study. Diabet Med 19:602–605PubMedCrossRef
19.
Zurück zum Zitat Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L (1999) Chronic complications in patients with slowly progressing autoimmune Type 1 diabetes (LADA). Diabetes Care 22:1347–1353PubMedCrossRef Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L (1999) Chronic complications in patients with slowly progressing autoimmune Type 1 diabetes (LADA). Diabetes Care 22:1347–1353PubMedCrossRef
20.
Zurück zum Zitat Schiel R, Muller UA (2000) GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33–40PubMedCrossRef Schiel R, Muller UA (2000) GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33–40PubMedCrossRef
21.
Zurück zum Zitat Kim CS, Park JA, Cho MH, Park JS, Nam JY, Kim DM, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC (2004) The frequency of Anti-GAD antibody in non-obese, adult-onset type 2 diabetes in Korea and clinical and biological characteristics according to anti-GAD antibody. J Korean Diabetes Assoc 28:66–74 Kim CS, Park JA, Cho MH, Park JS, Nam JY, Kim DM, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC (2004) The frequency of Anti-GAD antibody in non-obese, adult-onset type 2 diabetes in Korea and clinical and biological characteristics according to anti-GAD antibody. J Korean Diabetes Assoc 28:66–74
22.
Zurück zum Zitat Park YS (2004) The significance of anti-GAD antibodies in lean patients with type 2 diabetes mellitus. Korean Diabetes J 28:63–65 Park YS (2004) The significance of anti-GAD antibodies in lean patients with type 2 diabetes mellitus. Korean Diabetes J 28:63–65
23.
Zurück zum Zitat Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M (1996) The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241–245PubMedCrossRef Park Y, Lee H, Koh CS, Min H, Rowley M, Mackay IR, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M (1996) The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 19:241–245PubMedCrossRef
24.
Zurück zum Zitat Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y (1995) Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191–199PubMedCrossRef Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y (1995) Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191–199PubMedCrossRef
25.
Zurück zum Zitat Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y (1997) Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Exp Clin Endocrinol Diabetes 105:327–330PubMedCrossRef Inukai T, Fujiwara Y, Tayama K, Aso Y, Ogino K, Takemura Y (1997) Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Exp Clin Endocrinol Diabetes 105:327–330PubMedCrossRef
26.
Zurück zum Zitat Lee SA, Kim EY, Kim EH, Jeong JY, Jeong EH, Kim DW, Cho EH, Koh EH, Kim MS, Park JY, Lee KU (2009) Anti-GAD Antibody in patients with adult-onset diabetes in Korea. Korean Diabetes J 33:16–23CrossRef Lee SA, Kim EY, Kim EH, Jeong JY, Jeong EH, Kim DW, Cho EH, Koh EH, Kim MS, Park JY, Lee KU (2009) Anti-GAD Antibody in patients with adult-onset diabetes in Korea. Korean Diabetes J 33:16–23CrossRef
27.
Zurück zum Zitat Lee SH, Kwon HS, Yoo SJ, Ahn YB, Yoon KU, Cha BY, Lee KW, Son HY (2009) Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract 83:e62–e65PubMedCrossRef Lee SH, Kwon HS, Yoo SJ, Ahn YB, Yoon KU, Cha BY, Lee KW, Son HY (2009) Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract 83:e62–e65PubMedCrossRef
28.
Zurück zum Zitat Rosario PW, Reis JS, Amim R, Fagundes TA, Calsolari MR, Silva SC, Purisch S (2005) Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 28:1803–1804PubMedCrossRef Rosario PW, Reis JS, Amim R, Fagundes TA, Calsolari MR, Silva SC, Purisch S (2005) Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 28:1803–1804PubMedCrossRef
29.
Zurück zum Zitat Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie PD (2009) Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care 32:160–164PubMedCrossRef Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie PD (2009) Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care 32:160–164PubMedCrossRef
30.
Zurück zum Zitat Katulanda P, Shine B, Katulanda W, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR (2008) Diabetes mellitus among young adults in Sri Lanka-role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes Study. Diabetologia 51:1368–1374PubMedCrossRef Katulanda P, Shine B, Katulanda W, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR (2008) Diabetes mellitus among young adults in Sri Lanka-role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes Study. Diabetologia 51:1368–1374PubMedCrossRef
Metadaten
Titel
The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea
verfasst von
Mi-Oh Roh
Chan-Hee Jung
Bo-Yeon Kim
Ji-Oh Mok
Chul-Hee Kim
Publikationsdatum
01.04.2013
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0228-y

Weitere Artikel der Ausgabe 2/2013

Acta Diabetologica 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.